Health Care & Life Sciences » Pharmaceuticals | Sealand Securities Co. Ltd.

Sealand Securities Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,017
2,831
6,215
5,316
4,634
4,065
Unusual Expense
2
1
1
34
61
155
Pretax Income
474
964
2,449
1,426
571
141
Equity in Affiliates
-
1
1
1
1
1
Consolidated Net Income
343
715
1,841
1,066
431
112
Net Income
309
690
1,793
1,016
376
73
Net Income After Extraordinaries
309
690
1,793
1,016
376
73
Net Income Available to Common
309
690
1,793
1,016
376
73
EPS (Basic)
0.10
0.20
0.47
0.24
0.09
0.02
Basic Shares Outstanding
3,006
3,466
3,778
4,216
4,216
4,216
EPS (Diluted)
0.10
0.20
0.47
0.24
0.09
0.02
Diluted Shares Outstanding
3,006
3,466
3,778
4,216
4,216
4,216
Minority Interest Expense
34
25
48
50
55
39
Total Expense
1,552
1,897
3,777
3,884
4,034
3,794
Operating Income
465
934
2,438
1,432
600
271
Income Taxes
131
248
607
360
139
30
Non-Operating Income (Expense)
12
32
12
28
32
25

About Sealand Securities Co.

View Profile
Address
Guohai Building
Nanning Guangzi Zhuang 530028
China
Employees -
Website http://www.ghzq.com.cn
Updated 07/08/2019
Sealand Securities Co., Ltd. engages in the brokerage, trade, and investment of securities. It provides retail wealth management, corporate financial, sales transaction, asset management, credit, internet finance, research, fund, futures, direct investment, and consulting services. The company was founded on October 6, 1988 and is headquartered in Nanning, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.